Avidity Partners Management’s BELLUS Health Inc. BLU Stock Holding History

Avidity Partners Management’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,553,577	Closed	-$32.8M	–	113
2023 Q1	$32.8M	Sell	4,553,577 -46,421	-1%	-$360K	1.09%	35
2022 Q4	$37.8M	Buy	4,599,998 +253,298	+6%	+$2.36M	0.82%	39
2022 Q3	$45.9M	Buy	4,346,700 +81,700	+2%	+$868K	0.93%	35
2022 Q2	$39.4M	Buy	4,265,000 +580,000	+16%	+$4.74M	0.9%	32
2022 Q1	$25.4M	Sell	3,685,000 -90,000	-2%	-$580K	0.53%	49
2021 Q4	$30.4M	Sell	3,775,000 -1,167,000	-24%	-$7.74M	0.64%	47
2021 Q3	$30.3M	Buy	4,942,000 +692,000	+16%	+$2.62M	0.67%	48
2021 Q2	$13.2M	Sell	4,250,000 -2,547,400	-37%	-$9.73M	0.36%	63
2021 Q1	$26.1M	Buy	6,797,400 +1,071,400	+19%	+$4.07M	0.72%	49
2020 Q4	$17.5M	Buy	+5,726,000	New	+$15.5M	0.57%	52

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Avidity Partners Management's BLU Position: Q2 2023 in Review

Avidity Partners Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 4,553,577 shares — an estimated $32.8M sold.

Avidity Partners Management first reported a position in BLU in Q4 2020 and held it in 10 quarters. The position peaked at $45.9M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Avidity Partners Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Avidity Partners Management sold 4,553,577 BELLUS Health Inc. shares in Q2 2023, an estimated $32.8M.
Avidity Partners Management first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 10 quarters.
Avidity Partners Management's BELLUS Health Inc. position peaked at $45.9M in Q3 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Avidity Partners Management's 13F filing for Q2 2023, filed 14 Aug 2023.